ARWR vs CTRA · rev $829.4M vs P/E 15, rev $5.46B
Arrowhead Pharmaceuticals Inc (ARWR) versus Coterra Energy Inc (CTRA) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
ARWR currently screens at market cap $10.59B. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Not investment advice. Open the ARWR and CTRA stock pages for the full models.
Not investment advice.